Assessment of medication adherence in patients with Type 2 Diabetes and arterial hypertension: medication adherence in chronic disease

Detalhes bibliográficos
Autor(a) principal: Rosu, Amalia
Data de Publicação: 2024
Outros Autores: Coelho, André, Camacho, Pedro
Tipo de documento: Artigo
Idioma: por
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://doi.org/10.51126/revsalus.v6i1.594
Resumo: Aims: Assessment of medication adherence in newly diagnostic and treated patients with Type 2 Diabetes Mellitus and Arterial Hypertension, in the Primary Health Care Units of Lisbon and Tagus Valley. Methods: This is an observational and retrospective cohort study. The population is composed of newly diagnosed patients with Type 2 Diabetes Mellitus and Arterial Hypertension, at the beginning of treatment. Data was extracted from the Lisbon and Tagus Valley Regional Health Administration Information System. Medication adherence was assessed in three periods: patients started therapy or not after the professional's prescription (initiation); medication possession rate during the follow-up period (MPR) (implementation) and medication discontinuation, marks the end of therapy (discontinuation). Results: An initiation rate of 84.2% was obtained in patients with both diseases (98% for oral antidiabetic therapy and 84.6% for antihypertensive therapy). The implementation rates (MPR) for both diseases was only 3.4% (4.2% were considered adherent to oral antidiabetic therapy and 8.5% to antihypertensive therapy). The discontinuation rate was 3.4% (5.5% for oral antidiabetic therapy and 13.2% for antihypertensive therapy). Most patients initiate taking drugs after prescription but very few patients have a MPR enough to consider them having good adherence. Moreover, few patients discontinue the medication. Conclusions: Patients had a higher implementation rate to antihypertensive therapy but, on the other hand, were more persistent to the oral antidiabetic therapy. Through this new assessment, the medication adherence pattern seems to be influenced by the patient and by the disease itself.
id RCAP_9b5b203447aa5920fc6e85b15d37d239
oai_identifier_str oai:ojs.pkp.sfu.ca:article/594
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Assessment of medication adherence in patients with Type 2 Diabetes and arterial hypertension: medication adherence in chronic diseaseAvaliação da adesão à terapêutica em doentes com Diabetes Tipo 2 e hipertensão arterial: Adesão à medicação nas doenças crónicasArterial Hypertensionchronic diseaseinitiationmedication adherencepersistencetype 2 diabetes mellitusHipertensão Arterialdoença crónicainiciaçãoadesão à terapêuticapersistênciaDiabetes Mellitus tipo 2Aims: Assessment of medication adherence in newly diagnostic and treated patients with Type 2 Diabetes Mellitus and Arterial Hypertension, in the Primary Health Care Units of Lisbon and Tagus Valley. Methods: This is an observational and retrospective cohort study. The population is composed of newly diagnosed patients with Type 2 Diabetes Mellitus and Arterial Hypertension, at the beginning of treatment. Data was extracted from the Lisbon and Tagus Valley Regional Health Administration Information System. Medication adherence was assessed in three periods: patients started therapy or not after the professional's prescription (initiation); medication possession rate during the follow-up period (MPR) (implementation) and medication discontinuation, marks the end of therapy (discontinuation). Results: An initiation rate of 84.2% was obtained in patients with both diseases (98% for oral antidiabetic therapy and 84.6% for antihypertensive therapy). The implementation rates (MPR) for both diseases was only 3.4% (4.2% were considered adherent to oral antidiabetic therapy and 8.5% to antihypertensive therapy). The discontinuation rate was 3.4% (5.5% for oral antidiabetic therapy and 13.2% for antihypertensive therapy). Most patients initiate taking drugs after prescription but very few patients have a MPR enough to consider them having good adherence. Moreover, few patients discontinue the medication. Conclusions: Patients had a higher implementation rate to antihypertensive therapy but, on the other hand, were more persistent to the oral antidiabetic therapy. Through this new assessment, the medication adherence pattern seems to be influenced by the patient and by the disease itself.Objetivos: Avaliação da adesão à terapêutica em doentes recém-diagnosticados com Diabetes Mellitus tipo 2 e Hipertensão Arterial, nos Cuidados de Saúde Primários na Região Lisboa Vale Tejo. Metodologia: Estudo observacional de coorte retrospetivo. População composta pelos doentes recém-diagnosticados com Diabetes Mellitus tipo 2 e Hipertensão Arterial, em início de tratamento. Os dados foram extraídos do Sistema de Informação da Administração Regional de Saúde de Lisboa Vale Tejo. A adesão à terapêutica foi avaliada nas suas três componentes: se os doentes iniciaram a terapêutica prescrita (iniciação); através do Medication Possession Ratio (MPR) durante o período de seguimento (implementação) e a descontinuação da medicação, que marca o fim do tratamento (descontinuação). Resultados: A taxa de iniciação foi de 84.2% nos doentes com ambas as doenças (98% para a terapêutica antidiabética oral e 84.6% para a terapêutica anti-hipertensiva). A taxa de implementação (MPR) para ambas as doenças foi de, apenas 3.4% (4.2% foram considerados aderentes com a terapêutica antidiabética oral e 8.5% para a terapêutica anti-hipertensiva). A taxa de descontinuação foi de 3.4% (5.5% para a terapêutica antidiabética oral e 13.2% para terapêutica anti-hipertensiva). A maioria dos doentes iniciam a toma da medicação após a prescrição, mas poucos têm uma implementação suficiente para que a adesão seja considerada boa. Poucos doentes descontinuaram a medicação. Conclusão: Os doentes tiveram uma maior taxa de implementação à terapêutica anti-hipertensiva, mas, por outro lado, foram mais persistentes à terapêutica antidiabética oral. O padrão da adesão à terapêutica parece ser influenciado pelo doente e pela própria doença.Rede Académica das Ciências da Saúde da Lusofonia2024-03-13info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://doi.org/10.51126/revsalus.v6i1.594https://doi.org/10.51126/revsalus.v6i1.594RevSALUS - International Scientific Journal of the Academic Network of Health Sciences of Lusophone; Vol. 6 No. 1 (2024): RevSALUS - International Scientific Journal of RACSRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia; Vol. 6 Núm. 1 (2024): RevSALUS - Revista Científica Internacional da RACSRevSALUS - Revista Científica Internacional da Rede Académica das Ciências da Saúde da Lusofonia; Vol. 6 N.º 1 (2024): RevSALUS - Revista Científica Internacional da RACS2184-836X2184-486010.51126/dnsp0x19reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://revsalus.com/index.php/RevSALUS/article/view/594https://revsalus.com/index.php/RevSALUS/article/view/594/473Direitos de Autor (c) 2024 RevSALUS - Revista Científica Internacional da Rede Académica das Ciências da Saúde da Lusofoniainfo:eu-repo/semantics/openAccessRosu, AmaliaCoelho, AndréCamacho, PedroRosu, Amalia2024-03-17T15:01:46Zoai:ojs.pkp.sfu.ca:article/594Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T04:01:55.618470Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Assessment of medication adherence in patients with Type 2 Diabetes and arterial hypertension: medication adherence in chronic disease
Avaliação da adesão à terapêutica em doentes com Diabetes Tipo 2 e hipertensão arterial: Adesão à medicação nas doenças crónicas
title Assessment of medication adherence in patients with Type 2 Diabetes and arterial hypertension: medication adherence in chronic disease
spellingShingle Assessment of medication adherence in patients with Type 2 Diabetes and arterial hypertension: medication adherence in chronic disease
Rosu, Amalia
Arterial Hypertension
chronic disease
initiation
medication adherence
persistence
type 2 diabetes mellitus
Hipertensão Arterial
doença crónica
iniciação
adesão à terapêutica
persistência
Diabetes Mellitus tipo 2
title_short Assessment of medication adherence in patients with Type 2 Diabetes and arterial hypertension: medication adherence in chronic disease
title_full Assessment of medication adherence in patients with Type 2 Diabetes and arterial hypertension: medication adherence in chronic disease
title_fullStr Assessment of medication adherence in patients with Type 2 Diabetes and arterial hypertension: medication adherence in chronic disease
title_full_unstemmed Assessment of medication adherence in patients with Type 2 Diabetes and arterial hypertension: medication adherence in chronic disease
title_sort Assessment of medication adherence in patients with Type 2 Diabetes and arterial hypertension: medication adherence in chronic disease
author Rosu, Amalia
author_facet Rosu, Amalia
Coelho, André
Camacho, Pedro
author_role author
author2 Coelho, André
Camacho, Pedro
author2_role author
author
dc.contributor.author.fl_str_mv Rosu, Amalia
Coelho, André
Camacho, Pedro
Rosu, Amalia
dc.subject.por.fl_str_mv Arterial Hypertension
chronic disease
initiation
medication adherence
persistence
type 2 diabetes mellitus
Hipertensão Arterial
doença crónica
iniciação
adesão à terapêutica
persistência
Diabetes Mellitus tipo 2
topic Arterial Hypertension
chronic disease
initiation
medication adherence
persistence
type 2 diabetes mellitus
Hipertensão Arterial
doença crónica
iniciação
adesão à terapêutica
persistência
Diabetes Mellitus tipo 2
description Aims: Assessment of medication adherence in newly diagnostic and treated patients with Type 2 Diabetes Mellitus and Arterial Hypertension, in the Primary Health Care Units of Lisbon and Tagus Valley. Methods: This is an observational and retrospective cohort study. The population is composed of newly diagnosed patients with Type 2 Diabetes Mellitus and Arterial Hypertension, at the beginning of treatment. Data was extracted from the Lisbon and Tagus Valley Regional Health Administration Information System. Medication adherence was assessed in three periods: patients started therapy or not after the professional's prescription (initiation); medication possession rate during the follow-up period (MPR) (implementation) and medication discontinuation, marks the end of therapy (discontinuation). Results: An initiation rate of 84.2% was obtained in patients with both diseases (98% for oral antidiabetic therapy and 84.6% for antihypertensive therapy). The implementation rates (MPR) for both diseases was only 3.4% (4.2% were considered adherent to oral antidiabetic therapy and 8.5% to antihypertensive therapy). The discontinuation rate was 3.4% (5.5% for oral antidiabetic therapy and 13.2% for antihypertensive therapy). Most patients initiate taking drugs after prescription but very few patients have a MPR enough to consider them having good adherence. Moreover, few patients discontinue the medication. Conclusions: Patients had a higher implementation rate to antihypertensive therapy but, on the other hand, were more persistent to the oral antidiabetic therapy. Through this new assessment, the medication adherence pattern seems to be influenced by the patient and by the disease itself.
publishDate 2024
dc.date.none.fl_str_mv 2024-03-13
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://doi.org/10.51126/revsalus.v6i1.594
https://doi.org/10.51126/revsalus.v6i1.594
url https://doi.org/10.51126/revsalus.v6i1.594
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://revsalus.com/index.php/RevSALUS/article/view/594
https://revsalus.com/index.php/RevSALUS/article/view/594/473
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Rede Académica das Ciências da Saúde da Lusofonia
publisher.none.fl_str_mv Rede Académica das Ciências da Saúde da Lusofonia
dc.source.none.fl_str_mv RevSALUS - International Scientific Journal of the Academic Network of Health Sciences of Lusophone; Vol. 6 No. 1 (2024): RevSALUS - International Scientific Journal of RACS
RevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia; Vol. 6 Núm. 1 (2024): RevSALUS - Revista Científica Internacional da RACS
RevSALUS - Revista Científica Internacional da Rede Académica das Ciências da Saúde da Lusofonia; Vol. 6 N.º 1 (2024): RevSALUS - Revista Científica Internacional da RACS
2184-836X
2184-4860
10.51126/dnsp0x19
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799138191845883904